Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety of intrathecal infusion of cultured allogeneic umbilical cord-derived mesenchymal stem cells for amyotrophic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Umbilical Cord-Derived Mesenchymal Stem Cells (intrathecal) (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: SUSPENDED